Brigham and Women's Hospital, Boston, MA 02115, USA.
Circulation. 2010 Feb 9;121(5):626-34. doi: 10.1161/CIRCULATIONAHA.109.894774. Epub 2010 Jan 25.
Cardiac resynchronization therapy for heart failure with left bundle branch block reduces left ventricular (LV) conduction delay, contraction asynchrony, and LV end-systolic volume ("reverse remodeling"). Up to one third of patients do not improve, and the electric requirements for reverse remodeling are unclear. We hypothesized that reverse remodeling is predicted by the left bundle branch block ventricular activation sequence, the paced activation sequence, and interactions between these 2 conditions.
Twelve-lead ECGs during left bundle branch block and cardiac resynchronization therapy were analyzed in 202 consecutive patients (New York Heart Association class III to IV heart failure, ejection fraction < or =35%) for predictors of reverse remodeling (> or =10% reduction in end-systolic volume) at 6 months. Greater longest baseline LV activation time predicted increased odds of reverse remodeling (odds ratio [confidence interval]=1.30 [1.11, 1.52] per 10-ms increase), whereas higher QRS scores for LV scar predicted reduced reverse remodeling (odds ratio [confidence interval]=0.49 [0.27, 0.88] for each 1-point increase from 0 to 4; 0.92 [0.83, 1.01] for each 1-point increase >4). After cardiac resynchronization therapy, increasing R amplitudes in leads V(1) through V(2) (odds ratio [confidence interval]=2.76 [1.01, 7.51] for each 1x increase over [baseline Rx4.5]) and left-->right frontal axis shift (odds ratio [confidence interval]=2.00 [0.99, 4.02]), indicators of ventricular activation wavefront fusion, were positive predictors of reverse remodeling. Predicted probability of reverse remodeling ranged from <20% for patients with adverse predictors to 99% for those with positive predictors.
Ventricular activation with the use of the ECG accurately predicts LV reverse remodeling during cardiac resynchronization therapy. Greater longest baseline LV activation time and smaller scar volume combined with wavefront fusion on the paced ECG, anticipate higher probability of reverse remodeling.
心脏再同步治疗心力衰竭合并左束支传导阻滞可降低左心室(LV)传导延迟、收缩不同步和 LV 收缩末期容积(“逆重构”)。多达三分之一的患者没有改善,且逆转重构的电需求尚不清楚。我们假设,逆重构可由左束支传导阻滞心室激活顺序、起搏激活顺序以及这两种情况之间的相互作用来预测。
对 202 例连续患者(纽约心脏协会 III 至 IV 级心力衰竭,射血分数<或=35%)进行了左束支传导阻滞和心脏再同步治疗期间 12 导联心电图分析,以寻找 6 个月时逆重构(收缩末期容积>或=10%降低)的预测因素。较长的基线 LV 激活时间预测逆转重构的可能性增加(比值比[置信区间]=每增加 10 毫秒增加 1.30[1.11,1.52]),而 LV 瘢痕的 QRS 评分较高则预测逆转重构减少(比值比[置信区间]=从 0 到 4 每增加 1 分降低 0.49[0.27,0.88];从 4 到 1 每增加 1 分降低 0.92[0.83,1.01])。心脏再同步治疗后,V(1)到 V(2)导联的 R 波振幅增加(比值比[置信区间]=每增加 1x,增加 2.76[1.01,7.51])和左-右额面轴移位(比值比[置信区间]=每增加 1 分增加 2.00[0.99,4.02]),提示心室激动波前融合,是逆转重构的阳性预测因子。有不利预测因子的患者,其逆转重构的预测概率小于 20%,而有阳性预测因子的患者则为 99%。
心电图上心室激活的使用准确预测心脏再同步治疗期间 LV 逆重构。基线 LV 激活时间较长、瘢痕体积较小,起搏心电图上出现波前融合,预示着更高的逆转重构概率。